Brown David A, Yule David I
Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, NY 14642, USA.
Biochim Biophys Acta. 2010 Feb;1803(2):275-87. doi: 10.1016/j.bbamcr.2009.12.002. Epub 2009 Dec 21.
The P2X purinergic receptor sub-family of ligand-gated ion channels are subject to protein kinase modulation. We have previously demonstrated that P2X(4)R signaling can be positively regulated by increasing intracellular cAMP levels. The molecular mechanism underlying this effect was, however, unknown. The present study initially addressed whether protein kinase A (PKA) activation was required. Subsequently a mutational approach was utilized to determine which region of the receptor was required for this potentiation. In both DT-40 3KO and HEK-293 cells transiently expressing P2X(4)R, forskolin treatment enhanced ATP-mediated signaling. Specific PKA inhibitors prevented the forskolin-induced enhancement of ATP-mediated inward currents in P2X(4)R expressing HEK-293 cells. To define which region of the P2X(4)R was required for the potentiation, mutations were generated in the cytoplasmic C-terminal tail. It was determined that a limited region of the C-terminus, consisting of a non-canonical tyrosine based sorting motif, was required for the effects of PKA. Of note, this region does not harbor any recognizable PKA phosphorylation motifs, and no direct phosphorylation of P2X(4)R was detected, suggesting that PKA phosphorylation of an accessory protein interacts with the endocytosis motif in the C-terminus of the P2X(4)R. In support of this notion, using Total Internal Reflection Fluorescence Microscopy (TIRF)\ P2X(4)-EGFP was shown to accumulate at/near the plasma membrane following forskolin treatment. In addition, disrupting the endocytosis machinery using a dominant-negative dynamin construct also prevented the PKA-mediated enhancement of ATP-stimulated Ca(2+) signals. Our results are consistent with a novel mechanism of P2XR regulation, whereby PKA activity, without directly phosphorylating P2X(4)R, markedly enhances ATP-stimulated P2X(4)R currents and hence cytosolic Ca(2+) signals. This may occur at least in part, by altering the trafficking of a population of P2X(4)R present at the plasma membrane.
配体门控离子通道的P2X嘌呤能受体亚家族受蛋白激酶调节。我们之前已经证明,P2X(4)R信号传导可通过增加细胞内cAMP水平得到正向调节。然而,这种效应背后的分子机制尚不清楚。本研究首先探讨是否需要蛋白激酶A(PKA)激活。随后采用突变方法来确定受体的哪个区域对于这种增强作用是必需的。在瞬时表达P2X(4)R的DT-40 3KO细胞和HEK-293细胞中,福斯可林处理均增强了ATP介导的信号传导。特异性PKA抑制剂可阻止福斯可林诱导的表达P2X(4)R的HEK-293细胞中ATP介导的内向电流增强。为了确定P2X(4)R的哪个区域对于这种增强作用是必需的,在细胞质C末端尾巴中产生了突变。结果确定,C末端的一个有限区域,由一个非典型的基于酪氨酸的分选基序组成,是PKA发挥作用所必需的。值得注意的是,该区域没有任何可识别的PKA磷酸化基序,并且未检测到P2X(4)R的直接磷酸化,这表明辅助蛋白的PKA磷酸化与P2X(4)R C末端的内吞基序相互作用。支持这一观点的是,使用全内反射荧光显微镜(TIRF)显示,福斯可林处理后P2X(4)-EGFP在质膜处/附近积累。此外,使用显性负性发动蛋白构建体破坏内吞机制也可阻止PKA介导的ATP刺激的Ca(2+)信号增强。我们的结果与P2XR调节的一种新机制一致,即PKA活性在不直接磷酸化P2X(4)R的情况下,显著增强ATP刺激的P2X(4)R电流,从而增强胞质Ca(2+)信号。这可能至少部分是通过改变质膜上存在的一部分P2X(4)R的转运来实现的。